| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Muscle wasting | 2 | 0 | |
| Amyotrophic lateral sclerosis | 1 | 0 | |
| Cachexia | 1 | 0 | |
| Malnutrition | 1 | 6 | |
| Mitochondrial myopathy | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 6 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Muscle wasting | 2 | 0 | |
| Amyotrophic lateral sclerosis | 1 | 0 | |
| Cachexia | 1 | 0 | |
| Malnutrition | 1 | 6 | |
| Mitochondrial myopathy | 1 | 0 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 6 |